HGH vs Sermorelin
HGH and sermorelin are referenced in hormone optimisation and longevity clinic contexts. Compare provider governance, consultation depth, and monitoring standards.
HGH and sermorelin are often discussed in hormone optimisation settings, but clinics vary widely in how they frame each. This comparison is intended to help you evaluate provider transparency and clinical oversight.
HGH
Human growth hormone referenced in hormone optimisation and performance clinic contexts with strict prescribing requirements.
Potential benefits
- Sometimes listed in specialist hormone pathways.
- Typically offered within tightly controlled programmes.
Considerations
- Highly regulated with strict eligibility criteria.
- Requires clear clinical governance and monitoring.
Sermorelin
A growth hormone–releasing hormone analogue referenced in longevity protocols.
Potential benefits
- Common in longevity and hormone optimisation clinics.
- Often paired with other secretagogues.
Considerations
- Evidence and protocols vary by provider.
- Requires clinician-led assessment.
| Category | HGH | Sermorelin |
|---|---|---|
| Directory context | Recovery / performance-focused listing context. | Weight / metabolic or longevity listing context. |
| Common goals | Recovery support, injury pathways, performance. | Weight management, metabolic health, longevity programs. |
| Guidance note | Informational listing only; suitability requires clinician review. | Informational listing only; suitability requires clinician review. |
Related clinics
No tagged clinics yet for this comparison pair.
Conclusion
These options typically fall under specialist oversight. Focus on clinics with clear prescribing standards and monitoring plans rather than headline claims.